1 / 27

AMRITA INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE DEPARTMENT OF INTERNAL MEDICINE

DYSPNEA. Dyspnea is subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity .Dyspnea , a symptom , must be distinguished from signs of increased work of breathing.. Mechanisms of Dyspnea. Respiratory sensations are the consequence of

raimundo
Download Presentation

AMRITA INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE DEPARTMENT OF INTERNAL MEDICINE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. AMRITA INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE DEPARTMENT OF INTERNAL MEDICINE Dr.Vemuri Chaitanya Post Graduate Student M-1 UNIT

    2. DYSPNEA Dyspnea is subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity . Dyspnea , a symptom , must be distinguished from signs of increased work of breathing.

    3. Mechanisms of Dyspnea Respiratory sensations are the consequence of interactions b/w the efferent , motor output from the brain to the ventilatory muscles & afferent, sensory input from receptors throughout the body & integrative processing of this information that we infer must be occurring in the brain.

    4. Motor Efferents Disorders of ventilatory pump – increased work of breathing When muscles are weak/fatigued , greater effort is required even though other mechanics of system are normal.

    5. Sensory Afferents Chemoreceptors in carotid bodies & medulla activated by hypoxemia, acute hypercapnia and acidemia . Mechanoreceptors in lungs – stimulated by bronchospasm – chest tightness J-receptors – sensitive to interstitial edema Pulmonary vascular receptors – activated by acute changes in Pul.A pressure – air hunger. Metaboreceptors – skeletal muscle - exercise

    6. Efferent & Reafferent Mismatch Mimatch b/w feed forward message to ventilatory muscles & feedback from receptors that monitor response of ventilatory pump increases dyspnea (asthma, COPD)

    7. Physiological basis Increased ventilatory drive – 1. increase PaCo2—COPD 2. decreasePaO2—asthma,COPD, acidemia– diabetic ketoacidosis , lactic acidosis 3. fever 4. exercise

    8. Physiological basis Reduced ventilatory capacity - 1. decrease lung vol – restrictive lung ds (pneumonia,pul.edema,ILD) 2. Pleural pain 3. Increase resistance to airflow – asthma, COPD, upper airway &laryngeal obstruction.

    9. Assessing quality of dyspnea Descriptor Chest tightness Increased work of breathing Air hunger Cannot get a deep breath/ unsatisfying breath Rapid breathing Pathophysiology Bronchoconstriction,interstital edema Airway obst, neuromuscular ds Increase drive to breathe-CHF, pul.embolism, airway obst Hyperinflation(asthma,copd) , restricted tidal vol (pul.fibrosis) deconditioning

    10. History Timing, Place, Position at onset of symptoms. Mode of onset, duration , progression, severity Precipitating factors Ameliorating/ aggravating factors Associated symptoms ( wheezing, cough,sputum prod, pleuritic chest pain, excessive daytime sleepiness, peripheral /prox muscle weakness) Exposures – work place , tobacco , inhalants, pets, toxins Medications- beta blockers, methotrexate , bleomycin, nitrofurantoin, amiodarone Alterations in overall health status

    11. Dyspnea Intemittent dyspnea – reversible process (CHF,asthma,pul.embolism) Nocturnal dyspnea – CHF,GERD, asthma Orthopnea – (recumbent position)– CHF, ascites,pregnancy,obst.lung ds, resp.muscle weakness Platypnea – (upright position)- AVmalformations at lung bases, interatrial shunts, cirrhosis Dyspnea on exertion – cardiac/pulmonary

    12. Dyspnea Dyspnea independent of activity – mech (aspiration), allergic , psychological Trepopnea-(dyspnea in one lateral position but not the other) – pleural effusion , obst of prox tracheobronchial tree Paroxysmal nocturnal dyspnea – dyspnea, cough, frothy sputum streaked with blood, sweating, pallor , tachycardia , crackles – IHD, Aortic valve ds, AF, HTN, Cardiomyopathy.

    13. NYHA Classification Class 1 – No limitations.Ordinary physical activity does not cause dyspnea Class 2 – Slight limitation of physical activity. Class 3 – Marked limitation of physical activity. Class 4 – dyspnea at rest

    14. Physical Examination Respiratory Rate Body habitus – cachexia / obesity Posture – leaning forward on elbows with COPD, supine in bed Use of Accessory muscles Pursed lips Lower extremity edema – b/l – CHF & u/l – thromboembolism Clubbing – malignancy Cyanosis – insensitive sign of severe hypoxemia Extent & Symmetry of chest expansion

    15. Physical Examination Crackles, wheeze ( localised / diffuse ) Decreased breath sounds – pneumothorax , pleural effusion RV heave , increased P2 – pul.htn Elevated JVP , hepatojugular reflex, pedal edema – RV Failure Diffuse,lateral displaced pt of max impulse, S3 gallop ,crackles , elevated JVP – LV Failure

    16. A “PICTURE” OF THE PATIENT WHILE SYMPTOMATIC MAY WORTH THOUSANDS OF DOLLARS IN LABORATORY TESTS From Harrison by Richard M Schwartzstein

    17. Causes – Acute Severe Dyspnea Cardiac : Pul.edema from myocardial dysfn,including ischemia & valvular dysfn. Pulmonary : Acute severe asthma, Acute exacerbation of COPD, Pneumothorax, Pneumonia, Pul.embolism, ARDS, Inhaled Foreign body , Laryngeal edema, Lobar Collapse, Pul.H’age, Aspiration, Bronchiolitis obliterans , inhaled toxins Others : Metabolic acidosis , Psychogenic Hyperventilation

    18. Investigations For Acute Severe Dyspnea ABC – establish airway and ensure oxygenation CXR PA View Arterial Blood Gases measurements ECG V/Q Scan Echocardiogram Spirometry HRCT CT pulmonary angiography

    19. Remember Pulse Oximetry is not sufficient : Pt with N oxygenation & metabolic / resp acidosis can be dyspneic, -- need to exhale Co2 to raise pH. In Methemoglobinemia, the apparent O2 saturation is high , but actual PO2 is low.

    20. Causes of Chronic Dyspnea Cardiac : CHF, Myocardial dysfn- cardiomyopathies, cong.anomalies, intracardiac Rt to Lt shunts, arrhythmias. Valvular heart ds, Constrictive pericarditis Pulmonary : COPD, Chr.asthma, Bronchial.Ca, ILD, Chr.pul.thromboembolism, Large Pleural Effusion, Neuro muscular weakness Others : Severe Anaemia , Obesity, Extra- pulmonary restrictions ( kyphoscoliosis, pleural effusion, fibro thorax )

    21. Causes of Chronic Dyspnea Altered central ventilatory drive : central sleep apnea, obesity hypoventilation syn, idiopathic hyperventilation Metabolic : Increased metabolic needs (hyperthyroidism, obesity), Metabolic Acidosis ( renal failure ) Physiological : high altitude, vigorous exercise, pregnancy.

    22. Investigations For Chronic Dyspnea Careful & Comprehensive history & phy.ex to limit broad Diff.diagnosis. PFT, ABG, CXR PA View ECG Blood chemistries & CBC V/Q Scan Chest CT Thyroid Functioning Tests

    23. Investigations For Chronic Dyspnea Bronchoscopy Lung Biopsy Laryngoscopy

    24. Management Distinguishing Cardiovascular from Respiratory System Dyspnea : If the pt has both pul & cardiac ds , a Cardiopulmonary Exercise Test – to determine which system is responsible for exercise limitation. If ,at peak exercise , pt achieves predicted max ventilation – increase in dead space / hypoxaemia / bronchospasm – RS inv.

    25. Management If HR >85% of predicted max , if BP becomes very high / drops during exercise, ischemic changes in ECG – CVS inv. 1st goal of treatment is to correct the underlying problem responsible for dyspnea. If not possible , atleast lessen the intensity of dyspnea & its effect on pt’s quality of life

    26. Management Supplemental O2 – if resting O2 sat <90% COPD pts – pulmonary rehabilitation prog

    27. References Davidson’s Principles & Practice of Medicine Harrison’s Principles of Internal Medicine Macleod’s Clinical Examination Washington Manual

    28. THANK YOU ALL

More Related